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Abstract Noise exposure causes an excessive reactive
oxygen species (ROS) generation as an unwanted
byproduct of high metabolic activity. Oxidative stress and
antioxidative protective mechanisms have been therefore
proposed as the most interesting issues in the development
of noise-induced hearing loss. The aim of this study was to
examine changes in superoxide dismutase (SOD), catalase
(CAT) and the auditory brainstem response (ABR) in the
cochlea of C57BL/6 mice 1, 7 and 14 days after exposure
to 4 kHz octave band noise at the intensity of 110 dB SPL
for 8 h. The evaluation of three D-methionine (D-met) doses
(100, 200 and 400 mg/kg) has been performed in order to
choose an optimal concentration displaying most effec-
tively its antioxidant and thereby otoprotective functions.
Administering D-met at the dose of 400 mg/kg resulted in a
significant decrease in threshold shift (TS) independently
of the evaluation time after exposure to noise. SOD activity
was strongly supported by the same concentration
(400 mg/kg) of D-met. This effect was seen not shortly, but
7 and 14 days after exposure to noise. CAT activity was
induced only by noise and it reached the peak levels 7 days
after exposure. D-Met at the doses of 200 and 400 mg/kg
significantly decreased noise-induced changes in CAT
activity. The findings of this study indicate that the pro-
tective effect depends on the concentration of D-met and
can be fully expressed only when the drug is administered
in the dose 400 mg/kg.










NIHL Noise-induced hearing loss
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The factors underlying noise-dependent damages have a
complex nature. Although they are still under investigation,
the exact mechanisms leading to hearing loss have not been
fully understood so far. Oxidative stress and antioxidative
protective mechanisms have been proposed as the most
interesting issues in noise-related harmful effects [13].
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Since the cochlea is a metabolically active organ, sev-
eral reactive oxygen species (ROS) are generated under
normal metabolic circumstances and at relatively low
concentrations they may act as signaling molecules con-
trolling cell division, migration and contraction [28]. Noise
exposure leads to a dramatic change in cochlear blood
flow, including increased vascular permeability, capillary
vasoconstriction and blood stagnation in strial capillaries
[25]. This, in turn, causes an excessive ROS generation as
an unwanted byproduct of high metabolic activity. Super-
oxide anion, hydroxyl radicals and reactive nitrogen spe-
cies (RNS) [5, 34] as well as byproducts of lipid
peroxidation [26] and oxidative-induced DNA damage [31]
have been found to follow the intense noise exposure. Free
radicals may also induce cell death in the inner ear [33].
The reaction of free radicals and ROS on lipid molecules
may lead to continuing cell damage after noise exposure
[13]. ROS and RNS may also cause mitochondrial mem-
brane injury, cytochrome C release, and ischemia/reperfu-
sion damage in the inner ear [11, 13, 19, 20].
To counteract oxidative, as well as nitrosative insults,
cells have developed enzymatic defense system, such as
superoxide dismutase (SOD), catalase (CAT) and gluta-
thione peroxidase (GPX). SOD converts superoxide to
hydrogen peroxide which, in turn, is removed by CAT and
GPX. Mice deficient in SOD1 and GPX1 have been found
to be more susceptible to noise-induced hearing loss
(NIHL) than their wild-type littermates [27]. Additionally,
the increase in expression of glutathione in the lateral wall
of the cochlea and catalase in stria vascularis was observed
in animals after exposure to noise [16, 35]. In our previous
study, we have showed a significant early (on 1st day after
noise exposure) increase in SOD activity and late (on 7th
day after noise exposure) increase in CAT activity [29].
The existence of a specific window period during the post-
exposure phase, before the attainment of peak levels of
oxidative stress, has been suggested to be exploited for
appropriate pharmacological interventions, to limit the
noise-induced functional damage to cochlea.
As the extent of cochlear lesion progresses days after
acute noise exposure [15], the application of exogenous
antioxidants post-noise exposure has been suggested to
rescue from acoustic trauma. Certain degrees of protections
against NIHL were reported for such antioxidant molecules
as glutathione [26], ebselen [36], alpha-tocopherol [14],
acetyl-L-carnitine [7] and N-acetylcysteine (NAC) [10].
Moreover, Sergi et al. [30] investigated and confirmed
protective effect of idebenone, a synthetic analog of
coenzyme Q10 with antioxidant properties, in the rescue of
acoustic trauma. Many of the antioxidants, including these
that directly influence the availability of antioxidant pre-
cursors, are obtained from dietary sources. Permanent
hearing threshold shift has been seen in CBA/J mice
maintained on the diet supplemented with a combination of
beta-carotene, vitamins C and E and magnesium [21]. This
combination of nutrients, which produced significant
increases in plasma concentrations of vitamin C and E, and
Mg, also effectively reduced temporary hearing loss after
acute exposure to noise in guinea pigs [21, 22].
Nowadays, NIHL is irreversible which means that once
hearing impairment has occurred, there is no drug to cure
it. Currently there is no Food and Drug Administration-
approved drug to prevent NIHL. However, clinical trials of
drugs on humans with acoustic trauma are today becoming
a reality. Magnesium administration after acute noise expo-
sure was shown to be protective [1]. Currently two other drugs
are under evaluation: they are N-acetyl-L-cysteine and ebselen
[1, 24, 18]. In a series of experiments, [18] showed that
N-acetyl-L-cysteine (L-NAC), a precursor of glutathione,
protected hearing of chinchillas from the effects of a single
exposure to noise. The shortcoming of an effective use of
L-NAC in humans is that this drug does not readily cross the
blood–brain barrier, and should be used in much higher doses
than it is currently approved for clinical prescriptions.
The option for the future is D-methionine, an oral anti-
oxidative agent which is a natural component of cheese and
yogurt. Its otoprotective properties have been shown in
cisplatin-induced, carboplatin-induced and aminoglyco-
side-induced ototoxicity as well as permanent noise-
induced hearing loss [3]. In our previous publication we
showed that D-met intervention significantly reduced per-
manent threshold shifts (PTS) observed on the 14th day
post-exposure and prevented time-dependent changes in
SOD and CAT activity induced by noise [29].
Nowadays, there is a need to establish not only the benefit
of antioxidant therapy but also the dose of the otoprotective
agents. Since high drug doses may cause different side
effects, the search of minimal but still effective drug con-
centrations is overwhelming. Low-dose combinations of
compounds with different biochemical mechanisms of action
(e.g. D-met and L-NAC) have been suggested to allow long-
term administration with fewer side effects and equal efficacy
in recovery of hearing following continuous exposure to
noise [6]. The aim of this study was to examine the mecha-
nisms underlying the noise-induced increase in reactive
oxygen species in the inner ear and to find most efficient
doses of an antioxidant D-methionine to successfully prevent
the noise-induced functional damage to the mice cochlea.
Materials and methods
Animals
In total 400 6-week-old male C57BL/6 mice were used in
this study. We made every effort to reduce the number of
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animals to a minimum. Although we were performing
analysis in so young animals, there was still variability
observed for hearing thresholds before and after noise
exposure. For this reason before each experiment ABR
thresholds were measured in twice as much animals as
finally killed for biochemical analysis, in order to select the
most homogenous group for further analysis. This still
large number of mice is to be explained by the fact that the
biological material received from one animal was not
sufficient to perform many tests and, taking into account
the sort of experiment, animals could not be reused in
repetition experiments either. Furthermore, each experi-
ment was performed in several repetitions in order to
obtain reliable results. This experimental protocol was
approved by the Bioethical Committee at Nofer Institute of
Occupational Medicine (NIOM), Lodz, Poland (Resolution
No 54/LB383/2007). The animals were housed in groups of
four per cage and maintained in a temperature-controlled
room with a 12-h light/dark cycle and allowed free access
to food and water. Animal care was under the supervision
of the local Laboratory Animal Unit of NIOM.
The animals were randomly divided into five groups:
I. Control group (no exposure to noise nor administration
of D-met).
II. Noise-exposed group (exposed to noise only).
III. Noise ? D-met 100 group (exposed to noise and
treated with D-met in the dose 100 mg/kg).
IV. Noise ? D-met 200 group (exposed to noise and
treated with D-met in the dose 200 mg/kg).
V. Noise ? D-met 400 group (exposed to noise and
treated with D-met in the dose 400 mg/kg).
The ABR was performed in all 400 animals, while
biochemical analysis was done in 200 mice (40 animals
from each of subgroups I–V).
Noise exposure
The animals were exposed to 4 kHz octave band noise at
equivalent continuous sound pressure level of 110 dB
(SPL) in a ventilated sound exposure chamber for 8 h. The
noise was created using Sony Pictures Digital Sound Forge
8.0 software and delivered by a set of loudspeakers driven
by a Sony type D-NE005 player and LANEY CPX-115
active loudspeaker (Laney Amplification, Birmingham,
UK) to obtain a diffuse acoustic field. The uniformity of
distribution of sound pressure within the exposure chamber
was confirmed by multiple location measurements. The
noise parameters were monitored during the exposure by a
system that consisted of a Bru¨el & Kjaer type 4190
microphone (Bru¨el & Kjaer Sound & Vibration Measure-
ment, Denmark), a Svantek microphone preamplifier type
SV03 and a Svantek type SVAN 912 sound analyzer
(Svantek, Poland). The microphone was positioned at the
level of the animal’s head. The animals from the control
groups were placed in the exposure chamber for the same
period of time without turning on the noise generator, thus
controlling for handling stress.
Auditory brainstem response (ABR)
ABR was measured for each animal before and after noise
exposure. Prior to the measurements, the animals were
anesthetized with intramuscular injection of solution con-
taining xylazine (10 mg/kg) and ketamine (40 mg/kg). A
differential active needle electrode was placed subcutane-
ously below the test ear, a reference electrode at the vertex
and a ground electrode was positioned just above the hind
limb. The sound stimulus consisted of 12.5 ms tone bursts,
with a rise–fall time of 1 ms at a frequency of 8 kHz and
was generated using an Audio Generator of RACIA Cen-
tor-O system. The stimuli were presented to the external
auditory meatus at the intensity high enough to easily
identify ABR peaks and then the sound intensity was
decreased in 5-dB intervals near threshold. One thousand
tone presentations, delivered at 10/s, were averaged to
obtain a waveform, using a data acquisition system and a
microcomputer with RACIA software. Hearing threshold
was defined as the lowest intensity of stimulation that
yielded a repeatable waveform with an identifiable peak 1
or 2.
D-Methionine administration
D-Met (Sigma-Aldrich, Inc., USA) was dissolved in normal
saline and delivered by intraperitoneal injection. D-Met at
100, 200 or 400 mg/kg per dose was administered 1 h
before and 1 h after noise exposure. Additional doses were
administered twice a day at the same time intervals 1, 2 and
3 days following noise exposure. The volume of the
injection was 0.01 ml/g. The animals from control and
noise groups received at the same time an equivalent vol-
ume of saline. The animals from the group where the effect
of D-met was assessed 1 day after exposure were killed
after three injections and animals from the groups where D-




The animals were euthanized by decapitation. Cochleae
were dissected in cold phosphate-buffered saline [20 mM
sodium phosphate, pH 7.4; phosphate-buffered saline
(PBS)] and tissue from two cochleae (taken from one
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animal) were pooled for each sample, giving sufficient
material for performing SOD and CAT assays from the
same pool. The dissected specimens contained the tissues
of the lateral wall, the neuroepithelium and the cochlear
portion of the spiral ganglion. Cochlear homogenate
(whole cell extract) was prepared by freeze-grinding the
dissected cochleae in PBS. The homogenate was subjected
to low-speed centrifugation 3,0009g for 15 min at 4 C
and the supernatant was collected. Protein assay was done
using Bio-Rad Protein Assay (Bio-Rad Laboratories, CA,
USA).
SOD activity
The SOD activity in the cochlea was assessed using a SOD
Assay Kit (Cayman Chemical Company, Ann Arbor, MI,
USA) following the protocol given by the manufacturer.
CAT activity
The activity of CAT in cochlea was measured using a
Catalase Assay Kit (Cayman Chemical Company, Ann
Arbor, MI, USA) following the protocol given by the
manufacturer.
Statistical analysis
All results of the biochemical analysis were normalized
against given day’s control group for elimination of the
casual errors. The data collected were statistically analyzed
using one-way analysis of variance and significant differ-
ences between the various groups were evaluated using
Fisher’s test (STATISTICA 6.1).
Results
ABR
Inter-individual differences in the observed hearing
threshold levels were quite large and fluctuated from 15 to
40 dB before noise exposure and from 20 to 50 dB after
noise exposure. The ABR findings in the noise-exposed
group indicated a threshold shift (TS) of 22 dB at 8 kHz
immediately after noise exposure, which decreased within
the next days and stabilized by the 14th day post-exposure.
The lowest concentration of D-met of 100 mg/kg signifi-
cantly reduced noise-induced ABR threshold shift at 8 kHz
only 1 day after exposure to noise. For D-met administered
in the dose of 200 mg/kg, ABR threshold shift was sig-
nificantly lower both 1 and 7 days after exposure to noise,
suggesting only a partial protection. Significant differences
independent of evaluation time across all study groups
have been observed solely for the group with the highest
dose of D-met (i.e. 400 mg/kg), thereby indicating this
concentration as most effectively and fully protecting
against noise damage in C57BL/6 mice. No hearing
threshold shift was observed for the control animals 7 and
14 days post-exposure. ABR TS is presented in Fig. 1.
SOD activity
D-Met administered only in the concentration of 400 mg/kg
promoted the increase in SOD activity levels. This was
noticed 7 and 14 days after noise exposure (Fig. 2). The
increase observed at day 7 was significant when compared
with not-exposed animals (p = 0.0096), noise-exposed
animals (p = 0.0409), D-met in the dose of 100 mg/kg
(p = 0.0063) and 200 mg/kg (p = 0.0022). 14 days after
noise exposure, the difference in SOD activity level in D-
met 400 mg/kg group was still significantly higher, but
only when compared with not-exposed animals
(p = 0.013).
CAT activity
The increase in CAT activity levels was noticed 7 days
after exposure to noise. Here, the highest CAT activity was
induced by noise (p \ 0.0001). D-Met administration
resulted in the subsequent decrease in enzyme levels,
which yielded significant values only for drug doses of
200 mg/kg (p = 0.0014) and 400 mg/kg (p = 0.0065)
when compared with noise-exposed animals. This effect
was not seen for the dose of 100 mg/kg (Fig. 3).
Discussion
Methionine, unlike many amino acids, is reversibly oxi-
dized and has been found to serve as free radical scavenger
[32]. This ability explains why this drug is protective
against multiple types of factors leading to the irreversible
damage of the cochlea, like cisplatin, aminoglycosides or
noise. Its protective mode of action depends upon up-reg-
ulation of the anti-oxidant pathways. Campbell et al. [2]
have documented that D-met protects the activity levels of
sodium dismutase, catalase and glutathione reductase from
cisplatin-induced decrements. Additionally, methionine has
been reported to increase intracellular and mitochondrial
glutathione levels [9, 23], which may play a particularly
important role in prevention of noise-induced hearing loss,
as noise exposure alters the ratio between reduced and
oxidized glutathione in the cochlea [35].
Methionine is an indispensable amino acid for humans,
but there is evidence that if given in excess, it can interfere
with different metabolic pathways e.g. the utilization of
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nitrogen from dispensable amino acids (glycine is then
consumed to detoxify the excess of methionine and as a
consequence it become limiting for other metabolic pro-
cesses) or it may lead to vascular endothelial dysfunctions
[12]. Therefore, it is crucial to search for the lowest doses
of drugs that have protective effects and cause no or little
side effects. In our previous study we have found that
400 mg/kg of D-methionine is efficient in protecting
against hearing loss in C57BL/6 mice [29]. Since we have
found no data in the literature that would present the effects
of D-met doses higher than 400 mg/kg, we assume there is
probably no use in testing higher drug concentrations in
these animals.
In this study, the evaluation of three D-met doses (100,
200 and 400 mg/kg) has been performed in order to choose
concentration displaying most effectively its antioxidant
and thereby otoprotective functions in C57BL/6 mice.
Previously we have assessed the impact of 400 mg/kg D-
met on SOD, CAT activities and lipid peroxidation (LPO)
levels immediately and 1, 3, 7, 10, 14 and 21 days after
exposure to noise. The results of that study indicated the
presence of a specific window period during the post-
exposure phase, before the attainment of oxidative stress
peak levels, which could be exploited for the appropriate
pharmacological interventions, to limit noise-induced
functional damage to the cochlea [29]. The methodology of
the current study has been, however, slightly modified.
Taking into account our previous results, SOD and CAT
activity was evaluated only 1, 7 and 14 days post-exposure.
C57BL/6 mice were 6 weeks old and not 12 weeks old, to
provide better prevention against age-related hearing
impairment that could bias the real picture of ABR TS
Fig. 1 ABR threshold shifts in
study subgroups after exposure
to noise at 8 kHz. The whiskers
represent standard deviations.
Asterisk indicates significant
difference compared with the
group exposed to noise
(p \ 0.05)
Fig. 2 SOD activity levels in
study subgroups after quotient
normalization against given day
control group (relative values).
Significant difference in SOD
activity was observed on day 7
between D-met 400 mg/kg
group and all other groups, and
on day 14 between D-met
400 mg/kg and not exposed to
noise group (asterisks)
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related to noise exposure. For the biochemical assays two
cochleae from one animal, and not three from different
animals, were pooled for each sample to avoid any bias due
to interindividual differences.
Despite the very young age of animals we have observed
quite large inter-individual differences in their hearing
threshold levels before and after noise exposure. These
values, however, correspond well with the literature data,
as it was shown that in older mice pre-exposure hearing
threshold values at 8 kHz fluctuated from 45 to 50 dB [8,
17]. Slightly lower initial thresholds and larger variance
can be probably explained by younger age of the mice used
in our study. The ABR findings indicated a threshold shift
of 22 dB for 8 kHz immediately after noise exposure,
which decreased within the next days and stabilized by the
14th day post-exposure. We did not perform additional
ABR measurements after 14 days post-exposure, since in
our previous study we had shown that starting from the day
14 a stabilization of hearing threshold shifts can be
observed which lasts up to 21st day following exposure to
noise [29]. Administering D-met in the dose of 400 mg/kg
resulted in a significant decrease in TS independently of the
evaluation time after exposure to noise, which suggests that
this concentration can protect against permanent hearing
loss. The similar protective effect of D-met in this con-
centration was observed in our earlier study, however, the
decrease in PTS reached significant values only for 4 kHz
on 14th day after exposure to noise [29]. This discrepancy
can be explained by the fact that in the previous study older
animals (12 week old) were used and additionally, noise
exposure was shorter (4 h instead of 8). In the present study
lower drug concentrations also showed the tendency
toward ABR threshold shift decrease when compared with
noise-exposed animals. However, not all values reached
significant level, thereby suggesting only a partial protec-
tion of lower D-met concentrations.
Low D-met doses had been studied before by other
authors in the aspect of its otoprotective mode of action
after exposure to noise. It was shown that D-met in the
concentration of 200 mg/kg significantly protected against
permanent noise-induced ABR threshold shift at 2, 4, 6 and
8 kHz in chinchillas Laniger [3]. It was also shown that the
rescue with D-met at the dose 200 mg/kg may be delayed
for up to 7 h after noise exposure and still provides sig-
nificant protection from the permanent threshold shift [4].
In our study protective changes at D-met 200 mg/kg were
seen up to day 7 but not day 14. This discrepancy can be
explained by different study designs, i.e. different animals
used (6-week-old mice vs. 3-year-old chinchillas) and
different noise exposure conditions (110 dB SPL for 8 h in
our study vs. 105 dB SPL for 6 h in the study of Camp-
bell). A considerably lower dose of D-met (i.e. 12.5 mg/kg)
in combination with N-acetyl-L-cysteine was reported by
Clifford et al. [6] to be sufficient for significant recovery of
hearing after acoustic trauma in chinchillas. This, however,
again cannot be easily referred to the results of the current
study as we did not investigate low-dose combinations of
compounds with different biochemical mechanisms of
action. Moreover, none of the studies mentioned above
investigated biochemical changes following exposure to
noise and treatment with D-met.
Biochemical results of our study also indicated that SOD
activity was strongly supported only by the highest
(400 mg/kg) D-met concentration. This effect was seen not
shortly, but 7 and 14 days after exposure to noise. This
implied that lower drug doses did not effectively scavenge
free radicals. The similar mode of action was observed by
other authors for 300 mg/kg D-met, which promoted the
Fig. 3 CAT activity levels in
study subgroups after quotient
normalization against given day
control group (relative values).
Significant increase in CAT
activity level was observed in
noise-exposed group on the 7th
day post-exposure (asterisk1).
Significant difference in CAT
activity was observed on day 7
in D-met 200 mg/kg and
400 mg/kg groups when
compared with noise-exposed
group (asterisk2)
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SOD activity levels from cisplatin-induced decrements in
rats [2]. Contrary to D-met-induced increase in SOD
activity, the CAT activity was induced only by noise and it
reached the peak levels 7 days after exposure. Significant
decrease of noise-induced changes in CAT activity has
been noted for 200 and 400 mg/kg D-met doses, the latter
concentration being in concurrence with our previous
report [29].
Taking into account the results of ABR measurements
and the obtained results of SOD and CAT activity levels,
we assume that out of three D-met concentrations analyzed,
the highest (i.e. 400 mg/kg) is the most efficient in pre-
venting noise-induced cochlear damage in C57BL/6 mice.
D-Methionine displays multiple protective actions, but
probably works primarily as a direct and indirect antioxi-
dant. At least part of protection may be through guarding of
critical enzymes, including superoxide dismutase, hence
the reported increase in SOD activity levels after treatment
with D-Met. Another mode of action that would explain the
presented results is possibly the control of mitochondrial
glutathione levels which in turn could take over catalase
action in converting peroxide into water. Whether this
sufficiently explains the observed D-Met-induced decrease
in CAT activity level is a matter of debate and should be
further evaluated.
To conclude, D-methionine is an effective drug in
attenuating the noise-induced oxidative stress and associ-
ated functional hearing loss in C57BL/6 mice cochlea. The
protective effect depends on the dose of D-met and when
administered before exposure and up to 3 days after noise
exposure, is fully expressed only if the drug is administered
in the dose 400 mg/kg.
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